298 related articles for article (PubMed ID: 17059015)
1. [The clinical study on chronic hepatitis B treated by the four-step therapeutics of Traditional Chinese Medicine].
Yang HZ; Wang FL; Wang YZ; Shen WS; Xu GL; Yang YW; Huang XL
Zhong Yao Cai; 2006 Jul; 29(7):748-52. PubMed ID: 17059015
[TBL] [Abstract][Full Text] [Related]
2. [The effect of Cpd 861 on chronic hepatitis B related fibrosis and early cirrhosis: a randomized, double blind, placebo controlled clinical trial].
Yin SS; Wang BE; Wang TL; Jia JD; Qian LX
Zhonghua Gan Zang Bing Za Zhi; 2004 Aug; 12(8):467-70. PubMed ID: 15329205
[TBL] [Abstract][Full Text] [Related]
3. [Clinical study on treatment of cirrhosis by different dosages of salvia injection].
Ye F; Liu Y; Qiu G; Zhao Y; Liu M
Zhong Yao Cai; 2005 Sep; 28(9):850-4. PubMed ID: 16447879
[TBL] [Abstract][Full Text] [Related]
4. [The effect of he jie decoction on the TCRV beta 7 of chronic hepatitis B patients].
Zhang S; Cheng Z; Huang B; Li J
Zhong Yao Cai; 2002 Jun; 25(6):451-3. PubMed ID: 12583341
[TBL] [Abstract][Full Text] [Related]
5. [Clinical observations on effects on prognostic factor treating hepatitis B-related cirrhosis with purification purgation dispersion tonicity].
Yang H; Li C; Wang Y; Guan W; Yang Y
Zhong Yao Cai; 2003 Nov; 26(11):841-3. PubMed ID: 14989067
[TBL] [Abstract][Full Text] [Related]
6. [Evaluation on HBeAg conversion time when treating chronic hepatitis B patients with combination of lamivudine and traditional Chinese medicine].
Bai SL; Hu XY; Zhong S
Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Dec; 29(12):1243-7. PubMed ID: 19173973
[TBL] [Abstract][Full Text] [Related]
7. A higher alanine aminotransferase level correlates with earlier hepatitis B e antigen seroconversion in lamivudine-treated chronic hepatitis B patients.
Tseng TC; Liu CJ; Wang CC; Chen PJ; Lai MY; Kao JH; Chen DS
Liver Int; 2008 Aug; 28(7):1034-41. PubMed ID: 18492018
[TBL] [Abstract][Full Text] [Related]
8. Early response to lamivudine therapy in clinically non-cirrhotic chronic hepatitis B patients with decompensation.
Dai CY; Yu ML; Hsieh MY; Lee LP; Hou NJ; Huang JF; Chen SC; Lin ZY; Hsieh MY; Wang LY; Tsai JF; Chang WY; Chuang WL
Liver Int; 2007 Dec; 27(10):1364-70. PubMed ID: 17900250
[TBL] [Abstract][Full Text] [Related]
9. Association of baseline viral factors with response to lamivudine therapy in chronic hepatitis B patients with high serum alanine aminotransferase levels.
Tseng TC; Liu CJ; Wang CC; Chen PJ; Lai MY; Chen DS; Kao JH
Antivir Ther; 2009; 14(2):203-10. PubMed ID: 19430095
[TBL] [Abstract][Full Text] [Related]
10. [Effects of Kang Gang Qian Granule (KGQG) on clinical and pathological features in chronic hepatitis B patients].
Xiao HJ; Shi CG; Zhang AP; Li P; Fan ZS
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Dec; 21(4):369-71. PubMed ID: 18322606
[TBL] [Abstract][Full Text] [Related]
11. Two-year lamivudine treatment for hepatitis B e antigen-negative chronic hepatitis B: a double-blind, placebo-controlled trial.
Chan HL; Wang H; Niu J; Chim AM; Sung JJ
Antivir Ther; 2007; 12(3):345-53. PubMed ID: 17591024
[TBL] [Abstract][Full Text] [Related]
12. A 7-year study of lamivudine therapy for hepatitis B virus e antigen-positive chronic hepatitis B patients in China.
Yao GB; Zhu M; Cui ZY; Wang BE; Yao JL; Zeng MD
J Dig Dis; 2009 May; 10(2):131-7. PubMed ID: 19426396
[TBL] [Abstract][Full Text] [Related]
13. Chronic cirrhotic hepatitis B patients with a high incidence of hepatic decompensation after viral breakthrough with lamivudine-resistant mutants and during rescue treatment.
Joo MK; Yeon JE; Kim JH; Jung YK; Lee SJ; Kim JH; Yim HJ; Byun KS; Park JJ; Kim JS; Bak YT
Scand J Gastroenterol; 2008; 43(12):1514-21. PubMed ID: 18663665
[TBL] [Abstract][Full Text] [Related]
14. Comparison of interferon and lamivudine treatment in Japanese patients with HBeAg positive chronic hepatitis B.
Arase Y; Ikeda K; Suzuki F; Suzuki Y; Kobayashi M; Akuta N; Hosaka T; Sezaki H; Yatsuji H; Kawamura Y; Kobayashi M; Kumada H
J Med Virol; 2007 Sep; 79(9):1286-92. PubMed ID: 17607775
[TBL] [Abstract][Full Text] [Related]
15. Early mortality in Taiwanese lamivudine-treated patients with chronic hepatitis B-related decompensation: evaluation of the model for end-stage liver disease and index scoring systems as prognostic predictors.
Dai CY; Chuang WL; Hou NJ; Lee LP; Hsieh MY; Lin ZY; Chen SC; Huang JF; Hsieh MY; Wang LY; Tsai JF; Wen-Yu ; Yu ML
Clin Ther; 2006 Dec; 28(12):2081-92. PubMed ID: 17296464
[TBL] [Abstract][Full Text] [Related]
16. [Predictive factors of hepatitis B virus DNA negative conversion among patients with chronic hepatitis B during lamivudine therapy].
Chen JL; Wang L; Yan J; Zhang L; Yu H; Fan XL
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Sep; 21(3):273-5. PubMed ID: 17971944
[TBL] [Abstract][Full Text] [Related]
17. [Therapeutic efficacy and quality of life investigation of traditional Chinese medicine-based therapy of chronic hepatitis B-related liver fibrosis].
An J; Ni W; Qiao J
Zhonghua Gan Zang Bing Za Zhi; 2014 Jan; 22(1):30-2. PubMed ID: 24721240
[TBL] [Abstract][Full Text] [Related]
18. [The clinical study on decompensatory cirrhotic patients treated by Bie Jia Jian].
Wang YZ; Yang HZ; Lin BL; Xie HP; Li YW; Dai M
Zhong Yao Cai; 2007 Jun; 30(6):755-7. PubMed ID: 17918451
[TBL] [Abstract][Full Text] [Related]
19. [The value of serum markers in evaluating liver fibrotic changes].
Hu YY; Liu P; Liu C; Liu CH; Xu LM
Zhonghua Gan Zang Bing Za Zhi; 2006 Mar; 14(3):174-7. PubMed ID: 16556409
[TBL] [Abstract][Full Text] [Related]
20. Long-term follow-up of lamivudine treatment in patients with severe acute exacerbation of hepatitis B e antigen (HBeAg)-positive chronic hepatitis B.
Wong VW; Wong GL; Tsang SW; Hui AY; Chim AM; Yiu KK; Chan HY; Chan FK; Sung JJ; Chan HL
Antivir Ther; 2008; 13(4):571-9. PubMed ID: 18672536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
